Evotec
Hamburg, Germany
Purpose
to identify the best TB drug regimen candidates through non-clinical evaluation and prioritize them for clinical development in adaptive phase 2b/c studies
Division
Global Health
Date
May 2019
Region Served
GLOBAL
Committed amount
$23,792,249
Grant topic
Tuberculosis
Duration (months)
92
Grantee location
Hamburg, Germany
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.